MGSS is studying the molecular and cellular changes taking place in the brains of individuals that become depressed and commit suicide.

Not only does our environment influence our mental and physical health, it can also change the functioning of the genes we inherit at birth

The Programme d'accompagnement justice-santé mentale (PAJ-SM) at the Montreal Municipal Court.

Anne Crocker, PhD, and her team are exploring how the judicial process deals with people suffering from mental disorders, and are helping to set up a mental health court in Montreal.

The laboratory’s focus is on the neurons that use glutamate, an excitatory neurotransmitter that is key to the functioning of the central nervous system.

The laboratory directed by Bruno Giros, PhD, studies the molecular networks of dopamine and glutamate receptors and transporters, two neurotransmitters that play a key role in schizophrenia.

Directed by Cécilia Flores, PhD, the laboratory investigates brain abnormalities at the cellular and molecular level contributing to behaviours associated with schizophrenia and addiction.

The laboratory of Patricia Boksa, PhD, has shown that birth complications can change the way in which the brain’s dopamine systems respond to stress in adulthood.

Directed by Natalie Grizenko, MD, and Ridha Joober, MD, PhD, the laboratory studies the genetic and pharmacogenetic aspects of psychiatric disorders such as schizophrenia, ADHD and eating disorders.

Directed by Thomas Brown, PhD, and Christine Gianoulakis, PhD, the laboratory is researching the genetic etiology and underlying mechanisms of addiction as well as the markers of predisposition to addiction.